Expanded Access Program of Venetoclax and Navitoclax for Pediatric Patients with Relapsed or Refractory ALL or LL
NO_LONGER_AVAILABLE
Status
Conditions
- Relapsed Childhood ALL
- Relapsed Childhood Lymphoblastic Lymphoma
Interventions
- DRUG: Venetoclax
- DRUG: Navitoclax
Sponsor
Kathleen Ludwig